Active subscriptions up 92%: 12,050 active U.S. subscriptions as of October 28, 2026, up from 6,287 on October 14, 2026 Monthly subscription value up 94%: $1,787,585 at standard renewal pricing as of October 28, 2026, up from $919,945 on October 14, 2026 Order volume up 90%: 20,677 online checkout orders tracked as of October 28, 2026, up from 10,881 on October 14, 2026 Recurring growth: subscriptions renew on a recurring basis, building a growing base of repeat customers CHICAGO, IL / ACCESS Newswire / October 29, 2026 / Cosmos Health Inc. (" Cosmos Health " or the "Company") ( NASDAQ:COSM ), a diversified, vertically integrated global healthcare group, today provided an update on its U.S . direct-to-consumer subscription business. Two Weeks of Rapid Growth Cosmos Health launched its U.S . subscription model in mid-July 2026 and began scaling it in mid-September as it accelerated investment in its U.S . platform. On October 14, 2026 , the Company first reported 6,287 active U.S . subscriptions. Five days later, that number had risen 42% to 8,940. As of October 28, 2026 , it reached 12,050, up 35% in nine days and 92% in two weeks. Monthly subscription value, which represents the amount that would be billed on active subscriptions in a month at standard renewal pricing, grew even faster, rising 94% over the same two weeks, from $919,945 to $1,787,585 . Online checkout orders tracked by the Company's platform rose to 20,677, up 41% from 14,624 on October 19, 2026 and 90% from 10,881 on October 14, 2026 . Building a Recurring Revenue Base Subscriptions are central to the Company's U.S . strategy. Active subscriptions renew on a recurring basis, so every new subscriber represents an ongoing customer relationship rather than a single sale. As successive monthly cohorts of subscribers renew, the recurring portion of U.S . revenue is expected to grow, improving the visibility and predictability of the business. CEO Commentary Greg Siokas , CEO of Cosmos Health , stated: "Two weeks ago, we reported 6,287 active U.S . subscriptions. As of October 28 , we have 12,050, and the monthly value of our subscription base has nearly doubled to almost $1.8 million . We built this business in just a few months, and it is scaling rapidly. "What makes this growth so valuable is that it is recurring. Every new subscriber adds to a recurring revenue base that grows with each monthly cohort, giving us increasing visibility into future revenue. With the same model now live in Australia , New Zealand and the broader Oceania region, we are just getting started." About Cosmos Health Inc. Cosmos Health Inc. (NASDAQ: COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com , www.skypremiumlife.com , www.cana.gr , www.zipdoctor.co , www.cloudscreen.gr , as well as LinkedIn and X . Forward-Looking Statements With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans," and similar expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could," generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discus